Outcomes following Conformal Fractionated Stereotactic Boost and Temozolomide in Newly Diagnosed Glioblastoma Multiforme: A Long Term Analyses of Phase II Study

2010 ◽  
Vol 78 (3) ◽  
pp. S260
Author(s):  
M. Balducci ◽  
G. Chiloiro ◽  
S. Manfrida ◽  
A. Mangiola ◽  
G.R. D'Agostino ◽  
...  
Keyword(s):  
Glioblastoma Multiforme ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Newly Diagnosed ◽  
Newly Diagnosed Glioblastoma

Intensification of radiation therapy by temozolomide and fractionated stereotactic boost in newly diagnosed glioblastoma multiforme: A long-term analysis of a phase II study.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. e12515-e12515
Author(s):  
G. R. D'Agostino ◽  
G. Chiloiro ◽  
S. Manfrida ◽  
S. Chiesa ◽  
G. Apicella ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Glioblastoma Multiforme ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Newly Diagnosed ◽  
Newly Diagnosed Glioblastoma ◽  
Term Analysis

Phase II study of temozolomide (TMZ) administered on a 7 days on-7 days off regimen as primary treatment before radiotherapy (RT) in inoperable newly diagnosed glioblastoma multiforme (GBM)

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 1523-1523 ◽  
Author(s):  
O. Chinot ◽  
M. Barrié ◽  
A. Cournède ◽  
H. Dufour ◽  
D. Figarella-Branger ◽  
...  
Keyword(s):  
Glioblastoma Multiforme ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Primary Treatment ◽  
Newly Diagnosed ◽  
Newly Diagnosed Glioblastoma

Cilengitide in patients with newly diagnosed glioblastoma multiforme and unmethylated MGMT gene promoter: Protocol of a multicenter, randomized, open-label, controlled phase II study.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. TPS151-TPS151 ◽  
Author(s):  
L. B. Nabors ◽  
K. Fink ◽  
D. A. Reardon ◽  
G. J. Lesser ◽  
J. Trusheim ◽  
...  
Keyword(s):  
Glioblastoma Multiforme ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Gene Promoter ◽  
Newly Diagnosed ◽  
Open Label ◽  
Mgmt Gene ◽  
Newly Diagnosed Glioblastoma

scholarly journals Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study

2014 ◽  
Vol 53 (7) ◽  
pp. 939-944 ◽  
Author(s):  
Kenneth F. Hofland ◽  
Steinbjørn Hansen ◽  
Morten Sorensen ◽  
Silke Engelholm ◽  
Henrik P. Schultz ◽  
...  
Keyword(s):  
Glioblastoma Multiforme ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Newly Diagnosed ◽  
Concomitant Chemoradiotherapy ◽  
Randomized Phase Ii ◽  
Newly Diagnosed Glioblastoma

scholarly journals Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations

Cancer ◽  
2004 ◽  
Vol 100 (10) ◽  
pp. 2208-2214 ◽  
Author(s):  
Olivier-L. Chinot ◽  
Maryline Barrie ◽  
Elisabeth Frauger ◽  
Henry Dufour ◽  
Dominique Figarella-Branger ◽  
...  
Keyword(s):  
Glioblastoma Multiforme ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Newly Diagnosed ◽  
Elderly Populations ◽  
Newly Diagnosed Glioblastoma

2509 POSTER Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme (GBM): preliminary results

2007 ◽  
Vol 5 (4) ◽  
pp. 230
Author(s):  
C.M. Carapella ◽  
A. Felici ◽  
M.A. Mirri ◽  
A. Pace ◽  
M.A. Carosi ◽  
...  
Keyword(s):  
Glioblastoma Multiforme ◽  
Dose Rate ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Fixed Dose ◽  
Newly Diagnosed ◽  
Preliminary Results ◽  
Fixed Dose Rate ◽  
Newly Diagnosed Glioblastoma
Sign in / Sign up

Export Citation Format

Share Document